广发纳斯达克生物科技C人民币(016470)
动态评分： 5.71分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | OLMA | Olema Pharmaceuticals Inc | 5.04 | 0.03% |
| 2024-12-31 | AQST | Aquestive Therapeutics Inc | 4.9 | 0.03% |
| 2024-12-31 | NGNE | Neurogene Inc | 5.13 | 0.03% |
| 2024-12-31 | TSHA | Taysha Gene Therapies Inc | 5.35 | 0.03% |
| 2024-12-31 | TRVI | Trevi Therapeutics Inc | 4.78 | 0.03% |
| 2024-12-31 | SANA | Sana Biotechnology Inc | 5.49 | 0.03% |
| 2024-12-31 | ABSI | Absci Corp | 4.54 | 0.03% |
| 2024-12-31 | SLN | Silence Therapeutics plc ADR | 4.88 | 0.03% |
| 2024-12-31 | SLRN | ACELYRIN INC | 4.76 | 0.03% |
| 2024-12-31 | RIGL | Rigel Pharmaceuticals Inc | 4.47 | 0.03% |
| 2024-12-31 | SAGE | Sage Therapeutics Inc | 5.01 | 0.03% |
| 2024-12-31 | DSGN | Design Therapeutics Inc | 5.27 | 0.03% |
| 2024-12-31 | RVNC | Revance Therapeutics Inc | 4.81 | 0.03% |
| 2024-12-31 | VYGR | Voyager Therapeutics Inc | 4.67 | 0.03% |
| 2024-12-31 | CMPS | COMPASS Pathways plc ADR | 2.9 | 0.02% |
| 2024-12-31 | INZY | Inozyme Pharma Inc | 2.69 | 0.02% |
| 2024-12-31 | AVIR | Atea Pharmaceuticals Inc | 4.27 | 0.02% |
| 2024-12-31 | FDMT | 4D Molecular Therapeutics Inc | 3.89 | 0.02% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 3.96 | 0.02% |
| 2024-12-31 | MGNX | MacroGenics Inc | 3.08 | 0.02% |
公告&资料
